GLP‑1 boom lifts dairy protein demand

People taking GLP-1 weight-loss drugs are eating less, and food companies are racing to sell them more protein — especially whey and casein from dairy. (ajcn.nutrition.org) GLP-1 drugs such as Wegovy and Zepbound are prescribed with a reduced-calorie diet, and a 2025 clinical advisory from four U.S. medical and nutrition groups said treatment can bring gastrointestinal side effects, nutrient shortfalls, and loss of muscle and bone if diet and exercise are not managed closely. (novo-pi.com) (accessdata.fda.gov) (pmc.ncbi.nlm.nih.gov) That advisory said GLP-1 trials have produced average weight loss of 5% to 18%, but it also urged clinicians to assess muscle strength, function, and body composition and to pair higher protein intake with strength training rather than treat shakes alone as a fix. (pmc.ncbi.nlm.nih.gov) The demand signal is now showing up in dairy markets. A 2025 Food Policy paper estimated that GLP-1 use is reshaping food demand “particularly for protein,” and U.S. dairy exporters said whey protein powder and concentrate were among the strongest-performing categories in 2025. (sciencedirect.com) (idfa.org) Industry groups are tying that shift directly to new eating habits around the drugs. FAIR Health said the share of overweight or obese U.S. adults prescribed a GLP-1 for obesity or overweight rose 586.7% from 2019 to 2024, reaching just over 2% in 2024. (fairhealth.org) (fiercehealthcare.com) Whey is the part of milk left after cheesemaking, and processors can filter it into powders with more protein and less lactose or fat. That makes it easy to add to ready-to-drink shakes, bars, and smaller portions aimed at people whose appetite has dropped. (usdec.org) (jacoby.com) Prices suggest supply has tightened as buyers chase those ingredients. The U.S. Department of Agriculture said in February 2026 that whey protein concentrate 34% demand had strengthened, spot inventories remained tight, and manufacturers were prioritizing higher-protein products such as WPC 80% and whey protein isolate. (mymarketnews.ams.usda.gov) Dairy companies see a longer runway. Fonterra said in March 2026 that GLP-1 use was one of its top food-and-nutrition trends for the year and predicted more demand for protein powders, ready-to-drink shakes, and protein-fortified snacks. (foodingredientsfirst.com) Doctors and dietitians are not treating dairy protein as the whole answer. Cleveland Clinic guidance for patients on GLP-1 drugs focuses on protein-rich meals, hydration, and foods that reduce nausea and constipation, while the joint advisory says preserving muscle depends on resistance training as well as diet. (my.clevelandclinic.org) (pmc.ncbi.nlm.nih.gov) So the GLP-1 boom is not just changing pharmacy spending; it is also changing what food makers buy from dairies. As more patients eat less but try to hold on to muscle, whey and casein have become one of the clearest winners inside the grocery supply chain. (kff.org) (idfa.org)